The present study evaluated endogenous activities and the role of BMP and TGF-β, representative members of the TGF-β family, during myotube differentiation in C2C12 cells. Smad phosphorylation at the C-terminal serines was monitored, since TGF-β family members signal via the phosphorylation of Smads in a ligand-dependent manner.
INTRODUCTION
Members of the TGF-β family elicit their activities through a complex formation consisting of ligand, type I and type II receptor serine/threonine kinases. Activation of the type I receptor through transphosphorylation by the type II receptor induces the phosphorylation of C-terminal serines of receptor-regulated (R)-Smad. R-Smad is categorized into two subclasses: BMP pathway-specific R-Smad (Smad1, 5 and 8), and activin/TGF-β pathway-specific R-Smad (Smad2 and 3) [Feng and Derynck, 2005; Massagué et al., 2005; Heldin, 2008] . Subsequently, phosphorylated R-Smad forms complexes with common Smad, Smad4, which accumulate in the nucleus where they participate in transcriptional regulation of target genes. Thus, serine phosphorylation of R-Smad at the C-terminus is a key event in TGF-β family signaling [Feng and Derynck, 2005; Massagué et al., 2005; Heldin, 2008] . The objective of this study is to clarify the activities and roles of endogenous TGF-β family, especially BMPs and TGF-βs during myogenesis; the activities of the TGF-β family were monitored by the expression of phosphorylated R-Smad in a C2C12 myotube differentiation model.
MATERIALS AND METHODS

MATERIALS
The following reagents were purchased: recombinant BMP-2 and recombinant noggin were from R&D Systems (Minneapolis, MN); dorsomorphin and A-83-01 were from Calbiochem; LDN-193189 was from Stemgent (San Diego, CA); rabbit polyclonal antibody against phospho-Smad1 (Ser463/Ser465) / Smad5 (Ser463/Ser465)/ Smad8 (Ser426/Ser428) (#9511) and phospho-Smad2 (Ser465/Ser467) (#3101) were from Cell Signaling Technology; rabbit monoclonal antibody against Smad1 (ab33902), rabbit polyclonal antibody against Smad2 (ab63576), goat polyclonal antibody against Smad8 (ab48011), mouse monoclonal antibody against MyoD (ab16148) and β-actin were from Abcam; rabbit polyclonal antibody against Myf5 (C-20) was from Santa Cruz Biotechnology; mouse monoclonal antibody against myosin heavy chain (MyHC) (MY-32) was from Sigma; Alexa Fluoro 488 was from Invitrogen.
CELL CULTURE
C2C12 myoblasts were obtained from the American Type Culture Collection (Rockville, MD). Cells were cultured in growth medium, i.e., Dulbecco's modified Eagle's medium (DMEM) with heat-inactivated 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 µg/ml streptomycin, at 37°C under a humidified 5% CO2 atmosphere. To induce differentiation from myoblasts to myotubes, the medium was replaced at confluence (day 0) with differentiation medium consisting of DMEM with 2% horse serum supplemented the antibiotics. To examine the effect of dorsomorphin and LDN-193189, BMP-specific inhibitors [Yu et al., 2008a, b] , dorsomorphin at 4 µM, LDN-193189 at 100 nM or an equivalent amount of vehicle (DMSO: 0.04%) was added to growth medium from day -2 to day 0. To evaluate the effect of endogenous BMP activity, noggin, a BMP antagonist [Yanagita, 2005] , was also added at 2.5 or 25 ng/ml from day -2 to day 0. To examine the effect of A-83-01, an activin/TGF-β-specific inhibitor [Tojo et al., 2005] , A-83-01 at 4 µM or the indicated concentrations, or an equal amount of vehicle (DMSO: 0.08%) was added to differentiation medium from day 8 to day 12 or the indicated period.
WESTERN BLOTTING
To examine time-course changes in Smad expression, cells were recovered in 200 mM phosphate buffer, pH 7.4, 2 M NaCl, 2 mM Na3VO4, 1 mM PMSF and 1% aprotinin, and lysed by ultrasonication. Protein concentrations were measured by the Lowry method, and an equal amount of protein was subjected to Western blot analyses as described previously [Funaba and Murakami, 2008; Suenaga et al., 2010] . After incubation of the membranes with ECL Plus reagent (GE Healthcare), the chemiluminescent signals were captured and quantified by a LAS4000 mini biomolecular imager (Fuji Film, Tokyo, Japan) . To examine the effects of the inhibitor or BMP-2, cells were lysed in 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 with phosphatase and protease inhibitors.
RT-PCR and qRT-PCR
RNA isolation, RT-PCR and qRT-PCR were carried out as previously described [Furutani et al., 2009; Suenaga et al., 2010] . The following oligonucleotides were used as PCR primers: 5'-tgaaaacaccaggcgacata-3' and 5'-tgaggcattccgcatacac-3' for Smad1 (Genbank accession number: NM_008539), 5'-gccactgtagaaatgacaagaaga-3' and 5'-cactatcacttaggcactcagca-3' for Smad2 (NM_010754.4), 5'-cccagcacacaataacttgg-3' and 5'-cgctggttcagctcgtagta-3' for Smad3 (NM_016769.4), 5'-gcagtaacatgattcctcagacc-3' and 5'-gcgacaggctgaacatctct-3' for Smad5 (NM_008541.2), 5'-cggatgagctttgtgaagg-3' and 5'-gggtgctcgtgacatcct-3' for Smad8 (NM_019483), 5'-tggccatgatcttgctgtaa-3' and 5'-ccttgacttctaaaaagggattca-3' for Myostatin (NM_010834.2), 5'-gaggacccacggaagtga-3' and 5'-cctcagctgttggcagtagg-3' for Gremlin1 (NM_011824.3), and 5'-agcactacagtggcgactca-3' and 5'-ggccgctgtaatccatcat-3'
for MyoD (NM_010866.2). PCR primers of inhibitor of DNA binding (Id)s, TGF-β2, TGF-β3, Myf5, myosin heavy chain IIb (MyHC IIb), Hprt1, and Gapdh were previously described [Furutani et al., 2009; Murakami et al., 2009] . The relative mRNA level was expressed as a ratio with the Hprt1 mRNA level.
IMMUNOFLUORESCENCE STAINING
Cells cultured on glass coverslips were washed with phosphate-buffered saline (PBS), and fixed with 4% paraformaldehyde in PBS. The fixed cells were treated with 0.1%
Triton X-100 in PBS for permeabilization, followed by blocking with Ez Block (Atto, Tokyo, Japan) in TBS-T (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 20) for 30 min. Cells were subsequently reacted with the primary antibody against MyHC in TBS-T for 1 h at 37°C. After washing with TBS-T, cells were incubated with Alexa Fluoro 488 and 1 µg/ml 4',6-diamidino-2-phenylindole (DAPI) in TBS-T for 1 h. The number of nuclei was calculated by Image J (http://rsbweb.nih.gov/ij/). Fusion index was calculated as a ratio of the number of nuclei incorporated in myotubes to the number of total nuclei [Joulia et al., 2003] .
RESULTS
BMP ACTIVITY IS HIGHER BEFORE DIFFERENTIATION, WHEREAS TGF-β ACTIVITY IS HIGHER AFTER DIFFERENTIATION IN C2C12 CELLS
To examine changes in endogenous BMP and activin/TGF-β activities during the differentiation of committed myoblasts, we first examined the phosphorylation of Smad1/5/8 and Smad2, respectively, by Western blot analyses using an antibody that recognizes the phosphorylation of C-terminal serines (Fig. 1A) . When anti-phospho-Smad1/5/8 antibody was used, two bands were detected. Since the calculated molecular weight of Smad8 (48,420) is smaller than that of Smad1 (52, 157) and Smad5 (52, 172) , the lower band may indicate phosphorylated Smad8. In fact, the lower band corresponded to the band detected by anti-Smad8 antibody (data not shown).
The intensity of the lower band, i.e., phosphorylated Smad8, was higher before differentiation ( Fig. 1A , lanes 1 and 2), and rapidly decreased after differentiation stimulation (Fig. 1A, lanes 3-7, Fig. 1B ). By contrast, upper band intensity was relatively constant throughout the study. Since total Smad8 expression was also higher before differentiation (Fig. 1A, B) , the ratio of phosphorylated Smad8 to total Smad8 was relatively constant throughout the study (Fig. 1B) .
Western blot using anti-phosphorylated Smad2 antibody showed that a clear band was detected on day 8 to 16 (Fig. 1A , lanes 5-7, Fig. 1C ). The levels of total Smad2 were relatively lower but constant during myogenesis (Fig. 1A, C) . Thus, the ratio of phosphorylated Smad2 to total Smad2 was higher on day 8 to 16 (Fig. 1C) .
Gene transcript levels of Smad1 and Smad5 were constant throughout the study; the expression levels varied within 40% of the level on day -2 (Fig. 1D and E). By contrast, the level of Smad8 mRNA was decreased after differentiation stimulation to 16% of the basal level on day -2 (Fig. 1F) , which was consistent with that of Smad8 protein (Fig.   1A ). Variations of Smad2 and Smad3 expression were smaller during myogenesis, except for Smad3 expression on day 2 ( Fig. 1G and H).
Ids, proteins with an HLH domain lacking the basic domain [Norton, 2000] [Miyazono et al., 2010] . Thus, we also explored the known antagonists for the BMP pathway, of which the expression level was higher after differentiation stimulation. Gene transcript level of Gremlin1 was increased after differentiation stimulation ( Fig. 3A) , but the extent of the increase in Gremlin1 expression was relatively smaller (∼ 2-fold). Therefore, characteristic changes in endogenous BMP activity can not be completely explained by the regulatory expression of Gremlin1. BMPs in FBS may also be responsible for induction of phosphorylated Smad1/5/8; BMP-2 is relatively heat-stable, and heat-inactivation of FBS for 30 min at 56°C would not decrease the bioactivity of BMP-2 [Ohta et al., 2005] .
Gene transcript levels of TGF-β2 and TGF-β3 were increased after differentiation stimulation ( Fig. 3B and C). Especially, expression level of TGF-β2 on day 16 was ∼5-fold higher than that on day -2, implying the role as an inducer of phosphorylation of Smad2 during the late phase of myogenesis. Myostatin, also known as GDF-8, is a strong inhibitor of myogenesis in skeletal muscle, and transmits its signal through type I receptor for activin (ALK4) or TGF-β (ALK5) and subsequently via Smad2 [Rebbapragada et al., 2003 ]; however, no significant expression of Myostatin was detected ( Fig. 3D ). In addition, Smad2 phosphorylation was detected in response to exogenously administered TGF-β1 but not activin A (Fig. 3E , lanes 1-3). Thus, Smad2 activity in C2C12 cells reflects endogenous TGF-β activity but not Myostatin and activin activities.
PROPER BMP ACTIVITY BEFORE DIFFERENTIATION IS REQUIRED FOR DIFFERENTIATION OF C2C12 MYOBLASTS
Dorsomorphin is an inhibitor of the BMP pathway, which inhibits the activation of BMP type I receptors, i.e., ALK2, 3 and 6, but not ALK4 and 5 in several types of cells [Yu et al., 2008b; Suenaga et al., 2010] . Treatment with dorsomorphin significantly down-regulated the expression of Id1, indicating the effectiveness of this compound also in C2C12 myoblasts (Fig. 4A ). Immunofluorescent analyses revealed that treatment with dorsomorphin for 2 days before differentiation stimulation decreased myotube formation on day 8 (Fig. 4B ). Dorsomorphin treatment in undifferentiated C2C12 cells also decreased the expression of MyHC after differentiation stimulation (Fig. 4C, upper) , which was consistent with MyHC IIb mRNA on day 8 (Fig. 4D ). In addition, the treatment resulted in a lower expression of Myf5, especially on day 0 (Fig. 4C , middle).
Comparable results were also detected on gene transcript levels of Myf5 and MyoD on day 0 (Fig. 4E ).
Dorsomorphin was originally identified as an inhibitor for the AMPK pathway [Yu et al., 2008b] . Thus, results shown above may reflect effects of inhibition of endogenous AMPK activity. However, we could not detect phosphorylation of AMPKα1 at Ser485, a site of autophosphorylation [Hurley et al., 2006] (data not shown), suggesting that endogenous AMPK activity was lower. LDN-193189 is another inhibitor of BMP type I receptor, which is more selective and potent than dorsomorphin [Yu et al., 2008a] .
Treatment with LDN-193189 for 2 days before differentiation stimulation caused down-regulation of Id1, Myf5 and MyoD expression on day 0 (Fig. 5A-C) , and MyHC IIb expression on day 8 (Fig. 5D ). We further examined effects of pretreatment with noggin, a BMP antagonist [Yanagita, 2005] , for 2 days before differentiation stimulation.
Comparable results on expression of Id1, Myf5, MyoD and MyHC IIb were obtained ( Fig. 5E-H) . These results suggest that blocking BMP activity prior to differentiation stimulation impairs myotube formation, probably through down-regulation of MRF expression.
To test whether higher BMP activity in undifferentiated C2C12 cells enhances myogenic differentiation, BMP-2 was added to growth medium for 2 days before differentiation stimulation (Fig. 6) ; however, exogenous BMP-2 decreased myotube formation on 8 days after differentiation stimulation in a dose-dependent manner (Fig.   6A ). Expression of MyHC on day 8 was also decreased by BMP-2 addition both at the protein level (Fig. 6B) and at the mRNA level (Fig. 6C) . Furthermore, treatment with BMP-2 down-regulated the expression of MyoD (Fig. 6B and D) and Myf5 (Fig. 6D) .
Experiments using the inhibitor and ligand suggest that the appropriate level of BMP activity in undifferentiated proliferating myoblasts is necessary for efficient differentiation into myotubes.
ENDOGENOUS TGF-β ACTIVITY AFTER DIFFERENTIATION INHIBITS EXCESS MYOTUBE FORMATION IN C2C12 CELLS
We next examined the role of endogenous TGF-β activity during the period after differentiation. A-83-01 is an inhibitor of ALK4 and ALK5 [Tojo et al., 2005] ; as expected, the inhibitor blocked TGF-β1-induced Smad2 phosphorylation in C2C12 cells differentiated (MyoD-positive) and reserve (MyoD-negative) cells, which are undifferentiated but retain their myogenic potential [Yoshida et al., 1998 ]. Thus, these results suggest that the removal of endogenous TGF-β activity activates reserve cells, leading to differentiated myoblasts capable of differentiation into myotubes.
To examine whether inhibitory effect of endogenous TGF-β activity on myogenesis is limited to post-differentiation, A-83-01 was treated at various differentiation stages (Fig.   8A ). Treatment with A-83-01 not only after differentiation (stages B-D) but also prior to differentiation (stage A) increased MyHC expression on day 12, although the effect of A-83-01 was stronger at stages C and D than at stages A and B (Fig. 8B and C) . These results were consistent with gene transcript levels of MyHC IIb (Fig. 8D) . Expression of Myf5 and MyoD was also higher in C2C12 cells treated with A-83-01 at stage D (Fig.   8E ). Thus, endogenous TGF-β activity possibly inhibits myotube differentiation in a stage-independent manner.
DISCUSSION
Here we show differentiation-related changes in endogenous activities of the TGF-β family in C2C12 myoblasts. Endogenous BMP activity was higher in undifferentiated myoblasts, which was indispensable for myotube differentiation. Similar activity of BMP is shown during adipocyte differentiation; endogenous BMP activity in 3T3-L1 preadipocytes was higher before differentiation stimulation, and this activity is necessary for the preadipocytic property [Suenaga et al., 2010] . By contrast, TGF-β activity was relatively lower during the undifferentiated myoblast phase, and gradually increased after differentiation. Endogenous TGF-β activity negatively regulated myotube formation. The present results indicate that two representative TGF-β family members, i.e., TGF-β and BMP, endogenously control myogenesis in a stage-specific manner.
Previous studies revealed that the addition of BMP to low-mitogen differentiation medium inhibited myotube differentiation, and promoted osteoblast differentiation [Katagiri et al., 1994; Lee et al., 2000; Maeda et al., 2004] . BMP-induced expression of Id1 is suggested to mediate the inhibition of myogenesis [Katagiri et al., 1994; Vinals and Ventura, 2004] . Id1 heterodimerizes with E proteins, which interferes with the formation of the active complex of E proteins and MyoD. Thus, the Id1 and E protein complex inhibits the function MyoD to function as a transcription factor [Benezra et al., 1990; Sun et al., 1991] . In addition, Id1 expression also accelerated the degradation of myogenin [Vinals and Ventura, 2004] . In the present study, myogenesis was also inhibited by the short-term addition of BMP-2 to growth medium but not to differentiation medium. MRFs are possibly modulated as described above, since exogenous BMP-2 induced Id1 expression in C2C12 undifferentiated myoblasts ( cells under low-mitogen conditions [Olson et al., 1986] . However, TGF-β promoted myoblast differentiation under high-mitogen conditions in L6E9 myoblasts [Zentella and Massagué, 1992] , and stimulated the myogenic differentiation of uncommitted embryonic stem cells [Slager et al., 1993] . Culture conditions and cell differentiation stages possibly affect TGF-β effects. Furthermore, the expression of dominant-negative type II TGF-β receptor (TβRII), which lacks most of the cytoplasmic domain, including the kinase domain, delayed the differentiation of C2C12 myoblasts in low-mitogen differentiation medium [Filvaroff et al., 1994] . TβRII serine/threonine kinase also phosphorylated Par6, a regulator of cell polarity and tight-junction assembly, in a ligand-dependent manner [Ozdamar et al., 2005] . Thus, the kinase activity of TβRII beyond the phosphorylation of ALK5 may explain the discrepant results.
Other pathways including MAP kinase pathway, mTOR pathway and Hippo pathway regulate various stages of myoblast differentiation [Bennett and Tonks, 1997; Erbay and Chen, 2001; Park and Chen, 2005; Watt et al., 2010] . Since these pathways also affect TGF-β/BMP pathway [Feng and Derynck, 2005; Alarcón et al., 2009; Miyazono et al., 2010] , fine-tuning of myogenesis can be achieved through the complex cross-talk between pathways. Gene transcript levels of MyHC IIb on day 8 were quantified by qRT-PCR in C2C12
myoblasts treated with or without dorsomorphin (4 µM) for 2 days before differentiation. The expression was normalized to Hprt1 expression, and the expression in cells treated without the inhibitor was set to 1 (n = 3). 
